AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFTRIAXONE & SULBACTAM
30 registrations across 6 African markets— 18 active
Markets with CEFTRIAXONE & SULBACTAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CEZON-SB DRY POWDER FOR INJECTIOM | 🇷🇼Rwanda | STERILE INDIA PVT. LTD | active | Oct 2030 |
| BLUXONE-S INJECTION 1.5G | 🇬🇭Ghana | — | active | Jul 2028 |
| BLUXONE-S INJECTION 1.5G | 🇬🇭Ghana | — | active | Jul 2028 |
| CEFSULEX 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE IM/IV BOITE DE 1 | 🇨🇮Côte d'Ivoire | NIYA HEALTHCARE PVT. LTD | active | Jan 2028 |
| CEFEZONE S 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE IM/IV BOITE DE 1 | 🇨🇮Côte d'Ivoire | IMPACT HEALTH CARE PVT. LTD | expired | Jul 2025 |
| BECTACEF 1000MG/500MG POUDRE POUR SUSPENSION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | ZRENIE HEALTHCARE PVT LTD | expired | Jan 2025 |
| CEFAM 1000MG/500MG POUDRE POUR SUSPENSION INJECTABLE IM/IV BOITE DE 1 | 🇨🇮Côte d'Ivoire | LABORATOIRE SANTE PLUS PHAMACEUTICALS LL | expired | Feb 2024 |
| TRIXSON-S 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE IM/IV BOITE DE 1 | 🇨🇮Côte d'Ivoire | INDOCO REMEDIES LIMITED | expired | Feb 2024 |
| TRIAF-S 1000MG/500MG SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | RENA EXPORTS PVT LTD | expired | Feb 2024 |
| INDOZONE-S 1000MG/500MG SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | INDOLANDS PHARMA PVT LTD | expired | Dec 2023 |
| STERITAX 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | IPCA LABORATORIES LIMITED | expired | Jan 2023 |
| CEFTRIAXONE PLUS EBURNY 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE FLACON DE 10ML | 🇨🇮Côte d'Ivoire | EBURNY GROUP INC | expired | Jan 2023 |
| BACTECIN 1000MG/500MG POUDRE POUR SUSPENSION INJECTABLE EN IV FLACON DE 10ML | 🇨🇮Côte d'Ivoire | CIEL PHARMA PVT. LTD | expired | Jan 2023 |
| CEBACTUM_1500 1000/500MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2021 |
| ONECEF SB 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | KILITCH DRUGS LTD | expired | Jan 2021 |
| ELTRAGARD 1000MG/500MG POUDRE POUR SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | LABORATOIRE MOLCHEM LTD | expired | Jul 2020 |
| STERITAX ampoule injectable / 1000 mg / 500 ml | 🇸🇳Senegal | SOFIBEL-LABORATOIRE FUMOUZE | active | — |
| BECTACEF solution injectable / 1000 mg / 500 mg | 🇸🇳Senegal | ZRENIE HEALTHCARE | active | — |
| SULBACEF ampoule injectable / 1000 mg / 500 mg | 🇸🇳Senegal | EXPHA | active | — |
| INDOZONE-S solution injectable / 1.5G | 🇸🇳Senegal | INDOLANDS PHARMA | active | — |
| INDOZONE-S solution injectable / 1.5G | 🇸🇳Senegal | INDOLANDS PHARMA | active | — |
| CEFTRIAXONE +
SULBACTAM PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VIRCHOW HEALTHCARE PVT LTD | active | — |
| STERITAX ampoule injectable / 25 mg / 500 mg | 🇸🇳Senegal | IPICA LABORATOIRE | active | — |
| CEFTRIAXONE +
SULBACTAM PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VIRCHOW HEALTHCARE PVT LTD | active | — |
| CEFEZONE-S injection / 1,5 g | 🇸🇳Senegal | INTAS LABO | active | — |
| INDONOZONE S injectable / 1 g / 500 g | 🇸🇳Senegal | EST AFRICAN OVERSEAS. PLOT N°1, PHARMACITY, SELAQUI DEHRADUN-248 011, INDE | active | — |
| BECTACEF AMPOULE / 1000MG/500MG | 🇸🇳Senegal | ZRENIE | active | — |
| CEFEZONE-S injection / 1,5 g | 🇸🇳Senegal | INTAS LABO | active | — |
| LYCEF PLUS 1G/500MG SOLUTION INJECTABLE BOITE DE 1 | 🇨🇮Côte d'Ivoire | HEALTHILY PHARMA | active | — |
| BECTACEF AMPOULE / 1000MG/500MG | 🇸🇳Senegal | ZRENIE | active | — |
CEFTRIAXONE & SULBACTAM in Africa — Regulatory Overview
CEFTRIAXONE & SULBACTAM is registered across 6 African markets with 30 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Ghana, Uganda and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 30 registrations, 18 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.